Risk factors
Hyperion Defi (HYPD) risk factors
Item 1A of every Hyperion Defi, Inc. 10-K on file, and what changed from one year to the next.
- FY2025 10-K risk factors
48 risks, 35 new, 47 dropped, 7 reworded since the prior year. The company’s risk profile has shifted from biotech commercialization and financing to a concentrated HYPE-token treasury strategy.
Filed Mar 30, 2026 - FY2024 10-K risk factors
60 risks. Hyperion Defi faces imminent going concern risks with only $2.1 million in cash as of December 31, 2024. The company carries $10.2 million in debt under a loan agreement with Avenue maturing November 1, 2025. It depends entirely on successfully commercializing its Mydcombi and clobetasol propionate products or completing a proposed business combination with Betaliq.
Filed Apr 15, 2025